TrialBritish journal of cancer2020

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.

Daniel Eiger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.